Department of Histology and Embryology, School of Medicine, Akdeniz University, 07070 Antalya, Turkey.
Hum Reprod Update. 2021 Apr 21;27(3):570-583. doi: 10.1093/humupd/dmaa060.
Endometrium is a vital multicellular tissue for progression of pregnancy. Forkhead box O1 (FoxO1) transcription factor plays an important role in the endometrium as it regulates various cellular processes with its unique expression in different cell types.
This review focuses on the role of FoxO1 in endometrium with a particular emphasis on FoxO1 signaling in individual endometrial cell types during the menstrual cycle and early pregnancy.
A literature search was conducted in PubMed, Web of Science and Scopus to select studies reporting the role of FoxO1 in endometrium using the keywords: FoxO1, endometrium, menstrual cycle, early pregnancy, endometrial receptivity, implantation, decidualization, angiogenesis and neoplasia. Papers published before October 2020 were selected. Drawing on advances in laboratory science and preclinical studies, we performed a narrative review of the scientific literature to provide a timely update on the roles of FoxO1 during the menstrual cycle and early pregnancy.
FoxO1 is considered to be a decidualization marker in endometrial stromal cells, mainly because it regulates the transcription of decidual prolactin and insulin-like growth factor-binding protein 1 genes. Importantly, 507 of 3405 genes that are specifically regulated during decidualization of human endometrial stromal cells are expressed abnormally as a result of FOXO1 reduction. Epithelial FoxO1 is currently accepted as a novel endometrial receptivity marker for humans and mice owing to its timely and specific expression at the window of implantation. On the other hand, FOXO1 is essential in endometrial epithelial cell proliferation and differentiation to achieve endometrial homeostasis since loss of function of FOXO1 causes endometrial neoplasia. Last but not least, FoxO1 seems to act like a navigator molecule for embryo homing owing to its notably decreased nuclear expression in endometrial luminal epithelial cells, specifically at the blastocyst attachment region, which results in differentiation, entosis and apoptosis of endometrial epithelial cells during the peri-implantation period. In endothelium, FoxO1 expression coincides with the timing of increased vascular permeabilization during early pregnancy. There are limited data regarding the importance of FoxO1 upregulation in endometrial endothelial cells, therefore, it is time to investigate the role of endothelial FoxO1, which is the missing piece in the puzzle of the enigmatic endometrium. Another missing piece in the puzzle for the role of FoxO1 is on embryo development.
FoxO1 is a cell-specific core transcription factor involved in efficient endometrial remodeling during the menstrual cycle and early pregnancy. A better understanding of the role of FoxO1 as a decidualization marker, as an emerging marker of endometrial receptivity, and as a therapeutic target to prevent endometrial neoplasia could help us to make sense of endometrial biology and thus to improve the outcomes of ART in the clinic.
子宫内膜是妊娠进展的重要的多细胞组织。叉头框转录因子 O1(FoxO1)在子宫内膜中发挥着重要作用,因为它通过在不同的细胞类型中表达来调节各种细胞过程。
本综述重点介绍了 FoxO1 在子宫内膜中的作用,特别强调了 FoxO1 在月经周期和早孕期间单个子宫内膜细胞类型中的信号作用。
在 PubMed、Web of Science 和 Scopus 上进行文献检索,使用关键词“FoxO1、子宫内膜、月经周期、早孕、子宫内膜容受性、着床、蜕膜化、血管生成和肿瘤发生”,选择报道 FoxO1 在子宫内膜中作用的研究。选择 2020 年 10 月前发表的论文。借鉴实验室科学和临床前研究的进展,我们对科学文献进行了叙述性综述,及时更新了 FoxO1 在月经周期和早孕期间的作用。
FoxO1 被认为是子宫内膜基质细胞蜕膜化的标志物,主要是因为它调节蜕膜催乳素和胰岛素样生长因子结合蛋白 1 基因的转录。重要的是,由于 FOXO1 减少,3405 个在人子宫内膜基质细胞蜕膜化过程中特异性调节的基因中有 507 个表达异常。FoxO1 在人类和小鼠中被认为是一种新的子宫内膜容受性标志物,因为它在着床窗口期的表达是及时和特异的。另一方面,由于 FOXO1 的功能丧失会导致子宫内膜肿瘤发生,因此,它在子宫内膜上皮细胞的增殖和分化中对于实现子宫内膜的稳态至关重要。最后但并非最不重要的是,FoxO1 似乎是胚胎归巢的导航分子,因为其在子宫内膜腔上皮细胞中的核表达明显减少,特别是在囊胚附着区,导致子宫内膜上皮细胞在着床期的分化、侵入和凋亡。在内皮细胞中,FoxO1 的表达与早孕期间血管通透性增加的时间一致。关于 FoxO1 在子宫内膜内皮细胞中的上调的重要性的数据有限,因此,现在是时候研究内皮 FoxO1 的作用了,这是谜一般的子宫内膜拼图中缺失的一块。FoxO1 在胚胎发育中的作用是拼图的另一个缺失部分。
FoxO1 是一种细胞特异性核心转录因子,参与月经周期和早孕期间子宫内膜的有效重塑。更好地了解 FoxO1 作为蜕膜化标志物、新兴的子宫内膜容受性标志物以及作为预防子宫内膜肿瘤的治疗靶点的作用,可以帮助我们理解子宫内膜生物学,从而改善临床中辅助生殖技术的结局。